Stockscreener 앱 받기
35.94
1.55%
0.55
전일 마감가:
$35.39
열려 있는:
$35.45
하루 거래량:
85,663
Relative Volume:
0.19
시가총액:
$1.64B
수익:
$1.23B
순이익/손실:
$20.43M
주가수익비율:
81.48
EPS:
0.4411
순현금흐름:
$95.39M
1주 성능:
+3.19%
1개월 성능:
+10.14%
6개월 성능:
-4.24%
1년 성능:
+20.12%
1일 변동 폭
$35.23
$36.23
1주일 범위
$35.07
$37.32
52주 변동 폭
$29.06
$55.00
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HNGE, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
35.94 | 1.64B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
312.61 | 50.61B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
68.94 | 12.52B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
62.49 | 12.37B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
105.39 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.81 | 7.68B | 1.34B | 230.70M | 440.96M | 2.6695 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Is This the Right Time to Retain Omnicell Stock in Your Portfolio? - TradingView
Omnicell, Inc. (OMCL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Omnicell, Inc. (OMCL) stock price, news, quote and history - Yahoo Finance UK
Omnicell, Inc. (OMCL) stock price, news, quote and history - Yahoo Finance Singapore
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo! Finance Canada
Press Release: Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026 - Moomoo
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026 - Business Wire
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Does Omnicell’s Revenue Beat and Weak EBITDA Guidance Change The Bull Case For OMCL? - Yahoo Finance
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL) - Yahoo Finance
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Cost of goods sold of Omnicell, Inc. – HAN:OC9 - TradingView
Omnicell, Inc. Bonds — Corporate Bond Rates - TradingView
EBIT per share of Omnicell, Inc. – HAN:OC9 - TradingView
ETFs Investing in Omnicell, Inc. Stocks - TradingView
Omnicell (NasdaqGS:OMCL) Stock Forecast & Analyst Predictions - Simply Wall Street
Omnicell stock trades 39.95 percent below its yearly high - AD HOC NEWS
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo! Finance Canada
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Omnicell Inc (OC9.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Omnicell, Inc. (OMCL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Omnicell (OMCL) Stock Trades Below Fair Value After A 78% Slump - Yahoo Finance
3 Reasons OMCL is Risky and 1 Stock to Buy Instead - Yahoo Finance
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Precision Trading with Omnicell Inc. (OMCL) Risk Zones - Stock Traders Daily
Is Omnicell Inc (OMCL) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle By Investing.com - Investing.com Canada
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle By Investing.com - Investing.com India
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle - Investing.com
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle By Investing.com - Investing.com UK
Does Embedding TraceLink’s DSCSA Tools Into Omnicell Workflows Reframe Its Cloud and Recurring Revenue Story (OMCL)? - simplywall.st
Does Embedding TraceLink’s DSCSA Tools Into Omnicell Workflows Reframe Its Cloud and Recurring Revenue Story (OMCL)? - simplywall.st
Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations - marketscreener.com
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations - The Malaysian Reserve
Craig-Hallum Maintains Omnicell(OMCL.US) With Buy Rating - Moomoo
A new integration lets hospitals check medicines as they arrive - Stock Titan
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations - PR Newswire
Precision Trading with Omnicell Inc. (OMCL) Risk Zones - Stock Traders Daily
Omnicell Inc (OMCL) Stock Up 6.3% and Still Undervalued -- GF Sc - GuruFocus
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference - Yahoo Finance
Omnicell Inc. ($0.001 par value) (OMCL) Peer Comparison – Compare with Others - valueresearchonline.com
Omnicell Stock Price Forecast. Should You Buy OMCL? - StockInvest.us
Omnicell Inc. ($0.001 par value) (OMCL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Omnicell: Offers Good Value, But Uncertainty Remains (NASDAQ:OMCL) - Seeking Alpha
KeyBanc reiterates Omnicell stock rating on large pipeline growth By Investing.com - Investing.com Canada
KeyBanc reiterates Omnicell stock rating on large pipeline growth - Investing.com
Trillium Asset Management LLC Buys New Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
옴니셀 주식 (OMCL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Njoku Nnamdi | Officer |
Aug 17 '26 |
Proposed Sale |
36.85 |
3,083 |
113,609 |
0 |
| LIPPS RANDALL A | CHAIRMAN, CEO |
Jul 15 '26 |
Sale |
47.00 |
10,000 |
470,000 |
345,861 |
| Randall Lipps | Officer |
Jul 15 '26 |
Proposed Sale |
47.00 |
10,000 |
470,000 |
0 |
| Njoku Nnamdi | EVP, Chief Operating Officer |
May 18 '26 |
Sale |
43.22 |
3,090 |
133,550 |
154,785 |
| Manley Corey J | Officer |
May 18 '26 |
Proposed Sale |
43.22 |
5,025 |
217,180 |
0 |
| Njoku Nnamdi | Officer |
May 18 '26 |
Proposed Sale |
43.22 |
3,090 |
133,550 |
0 |
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
May 18 '26 |
Sale |
43.22 |
5,025 |
217,180 |
112,783 |
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
Mar 16 '26 |
Sale |
34.69 |
7,405 |
256,879 |
96,717 |
| Manley Corey J | Officer |
Mar 16 '26 |
Proposed Sale |
34.69 |
7,405 |
256,879 |
0 |
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
Feb 17 '26 |
Sale |
36.59 |
4,243 |
155,251 |
85,496 |
2.88%
자본화:
|
볼륨(24시간):